{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:18:25Z","timestamp":1786997905493,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002418","name":"China Academy of Chinese Medical Sciences Institute of Chinese Materia Medica","doi-asserted-by":"publisher","award":["2018-I2M-2-002"],"award-info":[{"award-number":["2018-I2M-2-002"]}],"id":[{"id":"10.13039\/501100002418","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.virusres.2026.199691","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T07:39:02Z","timestamp":1768030742000},"page":"199691","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Replication-incompetent viral vaccine vectors ChAdOx1 and MVA as tools for evaluating T-cell responses to naturally processed antigens in vitro"],"prefix":"10.1016","volume":"364","author":[{"given":"Salik","family":"Nazki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Rein\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reshma","family":"Kailath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9980-4505","authenticated-orcid":false,"given":"Bruno","family":"Douradinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virusres.2026.199691_bib0001","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/21645515.2018.1513439","article-title":"Poxviral promoters for improving the immunogenicity of MVA delivered vaccines","volume":"15","author":"Alharbi","year":"2019","journal-title":"Hum. Vaccin. Immun. Other."},{"key":"10.1016\/j.virusres.2026.199691_bib0002","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/oxfordjournals.aje.a121308","article-title":"Characterization of four new adenovirus serotypes isolated from chimpanzee tissue explants","volume":"94","author":"Basnight","year":"1971","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.virusres.2026.199691_bib0003","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.772240","article-title":"Intranasal delivery of MVA vector vaccine induces effective pulmonary immunity against SARS-CoV-2 in rodents","volume":"12","author":"Bo\u0161njak","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virusres.2026.199691_bib0004","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1080\/14760584.2023.2282065","article-title":"Have mRNA vaccines sentenced DNA vaccines to death?","volume":"22","author":"Cagigi","year":"2023","journal-title":"Expert. Rev. Vaccines."},{"key":"10.1016\/j.virusres.2026.199691_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2024.107367","article-title":"Orthoflavivirus zikaense (Zika) vaccines: what are we waiting for?","author":"Cagigi","year":"2024","journal-title":"Int. J. Antimicrob. Ag."},{"key":"10.1016\/j.virusres.2026.199691_bib0006","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0022-5223(03)00082-5","article-title":"Direct comparison of efficiency and stability of gene transfer into the mammalian heart using adeno-associated virus versus adenovirus vectors","volume":"126","author":"Chu","year":"2003","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.virusres.2026.199691_bib0007","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040385","article-title":"A novel Chimpanzee Adenovirus vector with low Human seroprevalence: improved systems for vector derivation and comparative immunogenicity","volume":"7","author":"Dicks","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.virusres.2026.199691_bib0008","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1084\/jem.20032044","article-title":"HIV-specific cytotoxic T cells from long-term survivors select a unique T cell receptor","volume":"200","author":"Dong","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.virusres.2026.199691_bib0009","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1476-8518-9-6","article-title":"Immunization with genetically attenuated P52-deficient plasmodium berghei sporozoites induces a long-lasting effector memory CD8+ T cell response in the liver","volume":"9","author":"Douradinha","year":"2011","journal-title":"J. Immune Based. Ther. Vaccines."},{"key":"10.1016\/j.virusres.2026.199691_bib0010","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms3836","article-title":"Protective CD8 + T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation","volume":"4","author":"Ewer","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virusres.2026.199691_bib0011","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12879-023-08139-6","article-title":"Epidemiological profile of arboviruses in two different scenarios: dengue circulation vs. dengue, chikungunya and Zika co-circulation","volume":"23","author":"Farias","year":"2023","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.virusres.2026.199691_bib0012","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3390\/vaccines7020040","article-title":"Safety and immunogenicity of a novel recombinant Simian Adenovirus ChAdOx2 as a vectored vaccine","volume":"7","author":"Folegatti","year":"2019","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virusres.2026.199691_bib0013","doi-asserted-by":"crossref","first-page":"5248","DOI":"10.1016\/j.vaccine.2022.06.008","article-title":"Vaccines based on the replication-deficient simian adenoviral vector ChAdOx1: standardized template with key considerations for a risk\/benefit assessment","volume":"40","author":"Folegatti","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2026.199691_bib0014","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1016\/j.vaccine.2013.03.020","article-title":"Clinical development of modified Vaccinia virus Ankara vaccines","volume":"31","author":"Gilbert","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2026.199691_bib0015","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.4049\/jimmunol.103.5.1089","article-title":"Serologic classification of Chimpanzee adenoviruses by hemagglutination and hemagglutination inhibition","volume":"103","author":"Hillis","year":"1969","journal-title":"J. Immunol."},{"key":"10.1016\/j.virusres.2026.199691_bib0016","first-page":"104","article-title":"Virulence and immunogenicity of a modified vaccinia virus (strain MVA)","volume":"144","author":"Hochstein-Mintzel","year":"1972","journal-title":"Z. Immunitatsforsch. Exp. Klin. Immunol."},{"key":"10.1016\/j.virusres.2026.199691_bib0017","doi-asserted-by":"crossref","first-page":"e663","DOI":"10.1016\/S2666-5247(22)00126-4","article-title":"Safety and immunogenicity of a simian-adenovirus-vectored rabies vaccine: an open-label, non-randomised, dose-escalation, first-in-human, single-centre, phase 1 clinical trial","volume":"3","author":"Jenkin","year":"2022","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.virusres.2026.199691_bib0018","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/bit.27945","article-title":"Manufacturing a chimpanzee adenovirus-vectored SARS-CoV-2 vaccine to meet global needs","volume":"119","author":"Joe","year":"2022","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.virusres.2026.199691_bib0019","first-page":"376","article-title":"Efficient transduction with recombinant Adenovirus in EBV-transformed B lymphoblastoid cell lines","volume":"37","author":"Kim","year":"2004","journal-title":"J. Biochem. Mol. Biol."},{"key":"10.1016\/j.virusres.2026.199691_bib0020","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1743-422X-7-21","article-title":"Evaluation of adenovirus capsid labeling versus transgene expression","volume":"7","author":"Li","year":"2010","journal-title":"Virol. J."},{"key":"10.1016\/j.virusres.2026.199691_bib0021","series-title":"Adenoviral Vectors for Gene Therapy","first-page":"27","article-title":"Biology of Adenovirus cell entry","author":"Luisoni","year":"2016"},{"key":"10.1016\/j.virusres.2026.199691_bib0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2008.11.045","article-title":"Risks associated with vaccinia virus in the laboratory","volume":"385","author":"MacNeil","year":"2009","journal-title":"Virology."},{"key":"10.1016\/j.virusres.2026.199691_bib0023","first-page":"375","article-title":"The smallpox vaccination strain MVA: marker, genetic structure, experience gained with the parenteral vaccination and behavior in organisms with a debilitated defence mechanism","volume":"167","author":"Mayr","year":"1978","journal-title":"Zentralbl. Bakteriol. B"},{"key":"10.1016\/j.virusres.2026.199691_bib0024","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/gt.2017.25","article-title":"Development of potent class II transactivator gene delivery systems capable of inducing de novo MHC II expression in human cells, in vitro and ex vivo","volume":"24","author":"Palma","year":"2017","journal-title":"Gene Ther."},{"key":"10.1016\/j.virusres.2026.199691_bib0025","doi-asserted-by":"crossref","first-page":"5183","DOI":"10.1007\/s00253-019-09842-8","article-title":"Genetically engineered probiotic Saccharomyces cerevisiae strains mature human dendritic cells and stimulate Gag-specific memory CD8(+) T cells ex vivo","volume":"103","author":"Palma","year":"2019","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.virusres.2026.199691_bib0026","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/s41590-020-0782-6","article-title":"Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19","volume":"21","author":"Peng","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.virusres.2026.199691_bib0027","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/infdis\/jiw244","article-title":"Safety and high level efficacy of the combination malaria vaccine regimen of RTS,S\/AS01 B with Chimpanzee Adenovirus 63 and modified Vaccinia Ankara vectored vaccines expressing ME-TRAP","volume":"214","author":"Rampling","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virusres.2026.199691_bib0028","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cellimm.2011.06.009","article-title":"CD3\u03b3-independent pathways in TCR-mediated signaling in mature T and iNKT lymphocytes","volume":"271","author":"Rein\u00e9","year":"2011","journal-title":"Cell Immunol."},{"key":"10.1016\/j.virusres.2026.199691_bib0029","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1016\/j.ymthe.2023.07.004","article-title":"Adenoviral vectors infect B lymphocytes in vivo","volume":"31","author":"Rice-Boucher","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.virusres.2026.199691_bib0030","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2025.2514356","article-title":"Developing the next-generation of adenoviral vector vaccines","volume":"21","author":"Sampson","year":"2025","journal-title":"Hum. Vaccin. ImmunOther"},{"key":"10.1016\/j.virusres.2026.199691_bib0031","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nm0498-397","article-title":"Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara","volume":"4","author":"Schneider","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.virusres.2026.199691_bib0032","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41586-020-2608-y","article-title":"ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques","volume":"586","author":"van Doremalen","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.virusres.2026.199691_bib0033","article-title":"Predictive markers of immunogenicity and efficacy for Human vaccines","volume":"9","author":"Van Tilbeurgh","year":"2021","journal-title":"Vaccines. (Basel)"},{"key":"10.1016\/j.virusres.2026.199691_bib0034","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1016\/j.vaccine.2012.02.016","article-title":"Biosafety aspects of modified vaccinia virus Ankara (MVA)-based vectors used for gene therapy or vaccination","volume":"30","author":"Verheust","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2026.199691_bib0035","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.virusres.2026.199691_bib0036","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1089\/hs.2020.0021","article-title":"Laboratory biosafety considerations of SARS-CoV-2 at biosafety level 2","volume":"18","author":"Wang","year":"2020","journal-title":"Health Secur."},{"key":"10.1016\/j.virusres.2026.199691_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112470","article-title":"Evaluation of T cell responses to naturally processed variant SARS-CoV-2 spike antigens in individuals following infection or vaccination","volume":"42","author":"Yin","year":"2023","journal-title":"Cell Rep."}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170226000080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170226000080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:37:18Z","timestamp":1773967038000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170226000080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":37,"alternative-id":["S0168170226000080"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2026.199691","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Replication-incompetent viral vaccine vectors ChAdOx1 and MVA as tools for evaluating T-cell responses to naturally processed antigens in vitro","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2026.199691","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"199691"}}